CORCEPT THERAPEUTICS INC Fair Value, Assets, Level 2 to Level 1 Transfers, Amount
CORCEPT THERAPEUTICS INC (CORT) had Fair Value, Assets, Level 2 to Level 1 Transfers, Amount of $0 as of 2018-09-30, per its 10-Q filed 2018-11-02.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount · last filed 2018-11-02
- 2018-09-30: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2018-06-30: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2018-03-31: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2017-12-31: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
| Period end | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount |
|---|---|
| 2018-09-30 | $0.00 10-Q · filed 2018-11-02 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-09 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-09 |
| 2017-12-31 | $0.00 10-K · filed 2018-02-28 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-03 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-02 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |